Form 4: BIO-TECHNE President Receives Stock Grant
Insider Transaction (Form 4)
Steven C. Crouse, President - Diag & Spatial Bi of BIO-TECHNE Corp, reported multiple transactions in common stock on August 17, 2026.
Summary
- Grant/award: acquired 8,702 Restricted Stock Units on August 17, 2026; holds 8,702 after (Direct).
- Grant/award: acquired 14,140 Restricted Stock Units on August 17, 2026; holds 14,140 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Steven C. Crouse — Officer (President - Diag & Spatial Bi)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-17 | Grant/award | Restricted Stock Units | 8,702 | — | — | 8,702 |
| 2026-08-17 | Grant/award | Restricted Stock Units | 14,140 | — | — | 14,140 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-17 | Grant/award (8,702 shares) |
| 2026-08-17 | Grant/award (14,140 shares) |
Keywords
insider transaction, Form 4, TECH, BIO-TECHNE Corp, neutral, Steven C. Crouse
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.